Advertisement
Home »

Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system.

Dec 11, 2023

ABOUT THE EXPERTS

  • Patrick M Jedlowski

    Division of Dermatology, University of Arizona College of Medicine – Tucson, Tucson, Arizona, USA.

    Jason P DuPont

    Division of Dermatology, University of Arizona College of Medicine – Tucson, Tucson, Arizona, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement